- Home
- FLUX vs NSPR Comparison
FLUX vs NSPR Comparison
Compare FLUX & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLUX
- NSPR
- Stock Information
- Founded
- FLUX N/A
- NSPR 2005
- Country
- FLUX United States
- NSPR United States
- Employees
- FLUX N/A
- NSPR N/A
- Industry
- FLUX Industrial Machinery/Components
- NSPR Medical/Dental Instruments
- Sector
- FLUX Miscellaneous
- NSPR Health Care
- Exchange
- FLUX Nasdaq
- NSPR Nasdaq
- Market Cap
- FLUX 98.5M
- NSPR 99.7M
- IPO Year
- FLUX N/A
- NSPR N/A
- Fundamental
- Price
- FLUX $2.37
- NSPR $2.21
- Analyst Decision
- FLUX Strong Buy
- NSPR Strong Buy
- Analyst Count
- FLUX 2
- NSPR 2
- Target Price
- FLUX $6.00
- NSPR $4.50
- AVG Volume (30 Days)
- FLUX 989.0K
- NSPR 70.5K
- Earning Date
- FLUX 09-16-2025
- NSPR 11-04-2025
- Dividend Yield
- FLUX N/A
- NSPR N/A
- EPS Growth
- FLUX N/A
- NSPR N/A
- EPS
- FLUX N/A
- NSPR N/A
- Revenue
- FLUX $66,434,000.00
- NSPR $7,066,000.00
- Revenue This Year
- FLUX $8.23
- NSPR $7.48
- Revenue Next Year
- FLUX $24.72
- NSPR $104.39
- P/E Ratio
- FLUX N/A
- NSPR N/A
- Revenue Growth
- FLUX 9.22
- NSPR 7.60
- 52 Week Low
- FLUX $1.15
- NSPR $1.99
- 52 Week High
- FLUX $7.55
- NSPR $3.80
- Technical
- Relative Strength Index (RSI)
- FLUX 33.10
- NSPR 34.18
- Support Level
- FLUX $5.06
- NSPR $2.21
- Resistance Level
- FLUX $7.55
- NSPR $2.41
- Average True Range (ATR)
- FLUX 0.93
- NSPR 0.10
- MACD
- FLUX -0.49
- NSPR -0.01
- Stochastic Oscillator
- FLUX 2.45
- NSPR 28.42
About FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.